Questions? +1 (202) 335-3939 Login
Trusted News Since 1995
A service for global professionals · Monday, December 17, 2018 · 471,308,858 Articles · 3+ Million Readers

Recent Analysis Shows Audentes Therapeutics, Endocyte, Bluerock Residential Growth REIT, Air Products and Chemicals, BWX Technologies, and Modine Manufacturing Market Influences — Renewed Outlook, Key Drivers of Growth

NEW YORK, Nov. 09, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of Audentes Therapeutics, Inc. (NASDAQ:BOLD), Endocyte, Inc. (NASDAQ:ECYT), Bluerock Residential Growth REIT, Inc. (NYSE:BRG), Air Products and Chemicals, Inc. (NYSE:APD), BWX Technologies, Inc. (NYSE:BWXT), and Modine Manufacturing Company (NYSE:MOD), including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.

/EIN News/ -- Complimentary Access: Research Reports

Full copies of recently published reports are available to readers at the links below.

BOLD DOWNLOAD: http://MarketSourceResearch.com/register/?so=BOLD
ECYT DOWNLOAD: http://MarketSourceResearch.com/register/?so=ECYT
BRG DOWNLOAD: http://MarketSourceResearch.com/register/?so=BRG
APD DOWNLOAD: http://MarketSourceResearch.com/register/?so=APD
BWXT DOWNLOAD: http://MarketSourceResearch.com/register/?so=BWXT
MOD DOWNLOAD: http://MarketSourceResearch.com/register/?so=MOD

(You may have to copy and paste the link into your browser and hit the [ENTER] key)

The new research reports from Market Source Research, available for free download at the links above, examine Audentes Therapeutics, Inc. (NASDAQ:BOLD), Endocyte, Inc. (NASDAQ:ECYT), Bluerock Residential Growth REIT, Inc. (NYSE:BRG), Air Products and Chemicals, Inc. (NYSE:APD), BWX Technologies, Inc. (NYSE:BWXT), and Modine Manufacturing Company (NYSE:MOD) on a fundamental level and outlines the overall demand for their products and services in addition to an in-depth review of the business strategy, management discussion, and overall direction going forward. Several excerpts from the recently released reports are available to today's readers below.

-----------------------------------------

Important Notice: the following excerpts are not designed to be standalone summaries and as such, important information may be missing from these samples. Please download the entire research report, free of charge, to ensure you are reading all relevant material information. All information in this release was accessed November 7th, 2018. Percentage calculations are performed after rounding. All amounts in millions (MM), except per share amounts.

-----------------------------------------

AUDENTES THERAPEUTICS, INC. (BOLD) REPORT OVERVIEW

Audentes Therapeutics' Recent Financial Performance

Analysts expect earnings to be released on March 14th, 2019. The report will be for the fiscal period ending December 31st, 2018. The reported EPS for the same quarter last year was -$0.82. The estimated EPS forecast for the next fiscal year is -$3.71 and is expected to report on March 14th, 2019.

To read the full Audentes Therapeutics, Inc. (BOLD) report, download it here: http://MarketSourceResearch.com/register/?so=BOLD

-----------------------------------------

ENDOCYTE, INC. (ECYT) REPORT OVERVIEW

Endocyte's Recent Financial Performance

For the three months ended June 30th, 2018 vs June 30th, 2017, Endocyte reported revenue of $0.01MM vs $0.01MM (up 16.00%) and analysts estimated basic earnings per share -$0.17 vs -$0.28. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Endocyte reported revenue of $0.07MM vs $0.07MM (unchanged) and analysts estimated basic earnings per share -$1.25 vs -$1.04. Analysts expect earnings to be released on February 25th, 2019. The report will be for the fiscal period ending December 31st, 2018. Reported EPS for the same quarter last year was -$0.18. The estimated EPS forecast for the next fiscal year is -$0.68 and is expected to report on February 25th, 2019.

To read the full Endocyte, Inc. (ECYT) report, download it here: http://MarketSourceResearch.com/register/?so=ECYT

-----------------------------------------

BLUEROCK RESIDENTIAL GROWTH REIT, INC. (BRG) REPORT OVERVIEW

Bluerock Residential Growth REIT's Recent Financial Performance

For the three months ended September 30th, 2018 vs September 30th, 2017, Bluerock Residential Growth REIT reported revenue of $47.88MM vs $30.15MM (up 58.77%) and analysts estimated basic earnings per share -$0.44 vs -$0.45. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Bluerock Residential Growth REIT reported revenue of $123.18MM vs $81.04MM (up 52.00%) and analysts estimated basic earnings per share -$1.79 vs -$0.91. Analysts expect earnings to be released on February 13th, 2019. The report will be for the fiscal period ending December 31st, 2018. Reported EPS for the same quarter last year was $0.13. The estimated EPS forecast for the next fiscal year is $0.51 and is expected to report on February 13th, 2019.

To read the full Bluerock Residential Growth REIT, Inc. (BRG) report, download it here: http://MarketSourceResearch.com/register/?so=BRG

-----------------------------------------

AIR PRODUCTS AND CHEMICALS, INC. (APD) REPORT OVERVIEW

Air Products and Chemicals' Recent Financial Performance

For the three months ended June 30th, 2018 vs June 30th, 2017, Air Products and Chemicals reported revenue of $2,259.00MM vs $2,121.90MM (up 6.46%) and basic earnings per share $2.16 vs $0.47 (up 359.57%). For the twelve months ended September 30th, 2017 vs September 30th, 2016, Air Products and Chemicals reported revenue of $8,187.60MM vs $7,503.70MM (up 9.11%) and analysts estimated basic earnings per share $13.76 vs $2.92 (up 371.23%). Analysts expect earnings to be released on January 25th, 2019. The report will be for the fiscal period ending December 31st, 2018. The reported EPS for the same quarter last year was $1.79. The estimated EPS forecast for the next fiscal year is $9.09 and is expected to report on November 5th, 2019.

To read the full Air Products and Chemicals, Inc. (APD) report, download it here: http://MarketSourceResearch.com/register/?so=APD

-----------------------------------------

BWX TECHNOLOGIES, INC. (BWXT) REPORT OVERVIEW

BWX Technologies' Recent Financial Performance

For the three months ended September 30th, 2018 vs September 30th, 2017, BWX Technologies reported revenue of $425.51MM vs $419.36MM (up 1.47%) and analysts estimated basic earnings per share $0.78 vs $0.47 (up 65.96%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, BWX Technologies reported revenue of $1,687.74MM vs $1,550.57MM (up 8.85%) and analysts estimated basic earnings per share $1.49 vs $1.79 (down 16.76%). Analysts expect earnings to be released on February 26th, 2019. The report will be for the fiscal period ending December 31st, 2018. The reported EPS for the same quarter last year was $0.47. The estimated EPS forecast for the next fiscal year is $2.88 and is expected to report on February 26th, 2019.

To read the full BWX Technologies, Inc. (BWXT) report, download it here: http://MarketSourceResearch.com/register/?so=BWXT

-----------------------------------------

MODINE MANUFACTURING COMPANY (MOD) REPORT OVERVIEW

Modine Manufacturing's Recent Financial Performance

For the three months ended September 30th, 2018 vs September 30th, 2017, Modine Manufacturing reported revenue of $548.90MM vs $508.30MM (up 7.99%) and analysts estimated basic earnings per share $0.76 vs $0.32 (up 137.50%). For the twelve months ended March 31st, 2018 vs March 31st, 2017, Modine Manufacturing reported revenue of $2,103.10MM vs $1,503.00MM (up 39.93%) and analysts estimated basic earnings per share $0.44 vs $0.29 (up 51.72%). Analysts expect earnings to be released on January 29th, 2019. The report will be for the fiscal period ending December 31st, 2018. The reported EPS for the same quarter last year was $0.35. The estimated EPS forecast for the next fiscal year is $1.82 and is expected to report on May 22nd, 2019.

To read the full Modine Manufacturing Company (MOD) report, download it here: http://MarketSourceResearch.com/register/?so=MOD

-----------------------------------------

ABOUT MARKET SOURCE RESEARCH

Market Source Research delivers the key research reports that helps serious investors, registered brokers, professional traders, and personal investment advisers find reliable information in today's markets. Market Source Research's team is comprised of financial professionals, many of which hold Chartered Financial Analyst® (CFA®) designations and FINRA® BrokerCheck® certifications. Whether identifying emerging trends, or discovering new opportunity, the team at Market Source Research is dedicated to providing accurate, informative, and objective content that's ahead of the curve. With insights on individual companies as well as sectors, readers get the industry's best available combination of big-picture perspective as well as granular detail.

REGISTERED MEMBER STATUS

Market Source Research's oversight and audit staff are registered analysts, brokers, and/or financial advisers ("Registered Members") working within Equity Research, Media, and Compliance departments. Market Source Research's roster includes qualified CFA® charterholders, licensed securities attorneys, and registered FINRA® members holding duly issued CRD® numbers. Current licensed status of several Registered Members at Market Source Research have been independently verified by an outside audit firm, including policy and audit records duly executed by Registered Members. Complaints, concerns, questions, or inquiries regarding this release should be directed to Market Source Research's Compliance department by Phone, at +1 (704) 343-6361, or by E-mail at compliance@MarketSourceResearch.com.

LEGAL NOTICES

Information contained herein is not an offer or solicitation to buy, hold, or sell any security. Market Source Research, Market Source Research members, and/or Market Source Research affiliates are not responsible for any gains or losses that result from the opinions expressed. Market Source Research makes no representations as to the completeness, accuracy, or timeliness of the material provided and all materials are subject to change without notice. Market Source Research has not been compensated for the publication of this press release by any of the above mentioned companies. Market Source Research is not a financial advisory firm, investment adviser, or broker-dealer, and does not undertake any activities that would require such registration. For our full disclaimer, disclosure, and terms of service please visit our website.

Media Contact:
Hugo Moreau, Media Department
Office: +1 (704) 343-6361
E-mail: media@MarketSourceResearch.com

© 2018 Market Source Research. All Rights Reserved. For republishing permissions, please contact a partner network manager at partnership@MarketSourceResearch.com.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

FINRA®, BrokerCheck®, and CRD® are registered trademarks owned by Financial Industry Regulatory Authority, Inc.

Powered by EIN News
Distribution channels:


EIN Presswire does not exercise editorial control over third-party content provided, uploaded, published, or distributed by users of EIN Presswire. We are a distributor, not a publisher, of 3rd party content. Such content may contain the views, opinions, statements, offers, and other material of the respective users, suppliers, participants, or authors.

Submit your press release